title: The role of interleukin-23/interleukin-17 axis in the development of systemic lupus erythematosus among patients with tuberculosis: comment on: Lin YC, Liang SJ, Liu YH et al.: tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan. (Rheumatol Int. 2011 Mar 18. [Epub ahead of print]).
authors.forename: Se Jin
authors.initials: SJ
authors.lastname: Park
authors.forename: Ji Hong
authors.initials: JH
authors.lastname: Kim
authors.forename: Tae Sun
authors.initials: TS
authors.lastname: Ha
authors.forename: Jae Il
authors.initials: JI
authors.lastname: Shin
mesh_terms: D019353:Endemic Diseases; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000453:epidemiology*; D008297:Male; D014376:Tuberculosis / Q000453:epidemiology*
references.citation: Cytokine. 2008 Feb;41(2):79-83
references.pmid: 18218322
references.citation: Clin Immunol. 2008 Jun;127(3):385-93
references.pmid: 18373953
references.citation: Rheumatol Int. 2013 Jan;33(1):271-2
references.pmid: 22090007
references.citation: J Immunol. 2010 May 1;184(9):4605-9
references.pmid: 20308633
references.citation: Arthritis Res Ther. 2010;12(2):R53
references.pmid: 20334681
references.citation: Nat Immunol. 2009 Jul;10(7):778-85
references.pmid: 19483719
references.citation: Cytokine Growth Factor Rev. 2010 Dec;21(6):455-62
references.pmid: 21075039